Partner
Partnership Models

Build, co-develop, or own – on your terms.

Three structured engagement models, each backed by Stabicon's full delivery ecosystem – from formulation to documentation to global market entry.

Model 01

White Label & Private Label

Ready-to-launch, validated platforms – branded as yours.

  • Pre-developed, validated product platforms
  • Full flexibility in branding, packaging and positioning
  • Multi-category access – Curcumin, D3, Magnesium and more
  • Faster market entry with reduced development cost
  • Scalable manufacturing – pilot to large-scale
  • End-to-end documentation and support
Discuss this model

Model 02

Co-Development

Built together – from concept to commercialization.

  • Collaborative formulation tailored to partner requirements
  • Custom ingredient selection for target market & positioning
  • Flexible development models – concept to commercialization
  • Technical expertise across R&D, analytics, and scale-up
  • Differentiated, competitively positioned products
  • Shared innovation and jointly built, high-efficacy lines
Discuss this model

Model 03

Exclusive Portfolio Partnerships

Own a defensible portfolio – by category or territory.

  • Category exclusivity – dedicated product lines
  • Territory protection options
  • Platform-based portfolio – multiple SKUs from one ingredient
  • Long-term strategic collaboration
  • Premium positioning with high-efficacy products
  • Build and own a unique, defensible portfolio
Discuss this model
How we build together

From inquiry to commercial launch – in six engineered steps.

Every partnership runs through the same scientific scaffold – predictable, documented and engineered around your filing geography. A nine-to-twelve month rhythm from first conversation to commercial readiness.

  1. Discovery

    01Inquiry & Briefing

    Week 1

    An exploratory conversation with our partnership team to surface your market opportunity, target indication, geography, regulatory ambition and preferred engagement model – white-label, co-development or exclusive territory.

    Deliverables

    • Mutual NDA
    • Capability deck walk-through
    • Hero ingredient & format short-list
  2. Scientific Scoping

    02Joint Scoping & TPP

    Weeks 2–4

    Our scientists co-define the Target Product Profile with you – dosage form, claim architecture, intended market(s), regulatory pathway and benchmark molecules. Stability, microbial and analytical scopes are framed.

    Deliverables

    • Target Product Profile (TPP)
    • Regulatory pathway map
    • Indicative timeline & cost envelope
  3. Tech Package

    03Formulation & Tech Package

    Months 2–4

    R&D hands over a partner-grade tech package – bench formulation, in-vitro performance, prototype samples, analytical methods (ICH Q2-aligned) and stability protocols against the chosen pharmacopoeial frame.

    Deliverables

    • Lab-scale prototype
    • Analytical method dossier
    • Stability protocol (ICH Q1A)
  4. Pilot

    04Pilot Batch & Validation

    Months 4–6

    Pilot-scale manufacturing under cGMP, supported by full microbial and stability sampling. Process robustness is mapped, packaging is finalized and a release-test plan is locked in.

    Deliverables

    • Pilot-scale validation batch
    • Stability initiation (long-term + accelerated)
    • Locked release-test plan
  5. Tech Transfer

    05Tech Transfer & Filings

    Months 6–9

    Lab-to-plant transfer is executed at Stabicon's manufacturing facility or a nominated partner site, with parallel preparation of regulatory dossier modules and submission readiness.

    Deliverables

    • Process performance qualification
    • Regulatory dossier modules
    • Partner training & SOPs
  6. Launch & Lifecycle

    06Commercial Launch & Lifecycle

    Month 9+

    Commercial release across your geographies, with ongoing stability monitoring, post-launch quality coordination and a lifecycle plan that opens room for line extensions, new formats and adjacent indications.

    Deliverables

    • Commercial release support
    • Lifecycle stability programme
    • Line-extension roadmap
Stabicon partnership in action – formulation development
Three engagement models

From private-label to co-development to exclusive portfolio rights – we build to fit your market.

Market Opportunity

The gap in today's nutraceutical market.

  • · Most supplements deliver limited systemic absorption
  • · Large doses required for minimal therapeutic impact
  • · Over-reliance on capsules and tablets
  • · Broad "wellness" claims vs targeted outcomes
  • · Price-driven competition with minimal differentiation
What partners need

The shift to high-efficacy products.

  • · Performance-driven, measurable outcomes
  • · Low-dose, high-impact formulations
  • · Convenient, consumer-friendly formats
  • · Therapy-led positioning over generic wellness
  • · Premiumization with scientific backing
Start a partnership

Three short steps – two working days to a response.

Drop in your details once. We'll route it to the right partnerships lead and follow up with a tailored capability deck.

Step 1 / 3

From shelf to daily routine

This isn't about a few SKUs. It's about owning everyday health.

Prefer email? Use our contact page
Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Unsubscribe in one click. Your email stays with us.

Press Kit

Logos, fact sheet & spokesperson bios – all in one download.

Download Press Kit (ZIP)

For media queries: press@stabicon.com

Accreditations

ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.